![Todd Chappell](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Todd Chappell
Geen lopende functies
Vermogen: - $ op 31-05-2024
Actieve functies van Todd Chappell
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
Biohealth Innovation, Inc.
![]() Biohealth Innovation, Inc. Financial ConglomeratesFinance Biohealth Innovation, Inc. sources and evaluates market-relevant bioheath intellectual properties, connects the IP with funding, and assists businesses in marketing and growth. It is a regional innovation intermediary that accelerates and facilitates technology transfer and commercialization of market-relevant research in federal labs, universities, and biohealth companies in the Region. The company was founded in 2011 and is headquartered in Rockville, MD. | Corporate Officer/Principal | 20-01-2014 | - |
Loopbaan van Todd Chappell
Eerdere bekende functies van Todd Chappell
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
Rasio Therapeutics, Inc. | Algemeen Directeur | 01-06-2019 | 01-03-2021 |
Crystalline Medical, Inc.
![]() Crystalline Medical, Inc. Electronic Equipment/InstrumentsElectronic Technology Crystalline Medical, Inc. develops solutions for the rapidly growing image-guided surgery market. Its technology provides for a forward-viewing, image-guided interventional probe that seeks to significantly improve both the safety and efficacy of millions of procedures per year in the areas of interventional radiology, cardiology, interventional oncology, pulmonology, and urology. The company was founded by Theodore P. Abraham in 2012 and is headquartered in Baltimore, MD. | Algemeen Directeur | - | - |
CombinatoRx, Inc.
![]() CombinatoRx, Inc. Pharmaceuticals: OtherHealth Technology CombinatoRx, Inc. develops new medicines built from synergistic combinations of approved drugs. The company develops biopharmaceutical products. It conducts clinical trials and research programs. The company was founded by Alexis Borisy, Brent R. Stockwell, Michael A. Foley, Curtis T. Keith and Jacob D. Goldfield in 2000 and is headquartered in Cambridge, MA | Corporate Officer/Principal | - | - |
TetraLogic Research & Development Corp.
![]() TetraLogic Research & Development Corp. BiotechnologyHealth Technology TetraLogic Research & Development Corp. develops SHP-141 topical HDAC inhibitor clinical development for cutaneous T cell lymphoma. Its currently conducting a randomized, double-blind, placebo controlled, phase 1b study, to evaluate the safety and tolerability of SHP-141 in patients with stage 1A, 1B or 2A CTCL. The company was founded by James E. Bradner and Ralph Mazitschek in 2008 and is headquartered in Cambridge, MA. | Operationeel Directeur | 01-01-2009 | - |
Opleiding van Todd Chappell
University of California, Los Angeles | Undergraduate Degree |
Questrom School of Business | Masters Business Admin |
Statistieken
Internationaal
Verenigde Staten | 8 |
Operationeel
Chief Operating Officer | 3 |
Chief Executive Officer | 3 |
Corporate Officer/Principal | 2 |
Sectoraal
Health Technology | 3 |
Consumer Services | 3 |
Finance | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Bedrijven in privébezit | 5 |
---|---|
CombinatoRx, Inc.
![]() CombinatoRx, Inc. Pharmaceuticals: OtherHealth Technology CombinatoRx, Inc. develops new medicines built from synergistic combinations of approved drugs. The company develops biopharmaceutical products. It conducts clinical trials and research programs. The company was founded by Alexis Borisy, Brent R. Stockwell, Michael A. Foley, Curtis T. Keith and Jacob D. Goldfield in 2000 and is headquartered in Cambridge, MA | Health Technology |
TetraLogic Research & Development Corp.
![]() TetraLogic Research & Development Corp. BiotechnologyHealth Technology TetraLogic Research & Development Corp. develops SHP-141 topical HDAC inhibitor clinical development for cutaneous T cell lymphoma. Its currently conducting a randomized, double-blind, placebo controlled, phase 1b study, to evaluate the safety and tolerability of SHP-141 in patients with stage 1A, 1B or 2A CTCL. The company was founded by James E. Bradner and Ralph Mazitschek in 2008 and is headquartered in Cambridge, MA. | Health Technology |
Biohealth Innovation, Inc.
![]() Biohealth Innovation, Inc. Financial ConglomeratesFinance Biohealth Innovation, Inc. sources and evaluates market-relevant bioheath intellectual properties, connects the IP with funding, and assists businesses in marketing and growth. It is a regional innovation intermediary that accelerates and facilitates technology transfer and commercialization of market-relevant research in federal labs, universities, and biohealth companies in the Region. The company was founded in 2011 and is headquartered in Rockville, MD. | Finance |
Crystalline Medical, Inc.
![]() Crystalline Medical, Inc. Electronic Equipment/InstrumentsElectronic Technology Crystalline Medical, Inc. develops solutions for the rapidly growing image-guided surgery market. Its technology provides for a forward-viewing, image-guided interventional probe that seeks to significantly improve both the safety and efficacy of millions of procedures per year in the areas of interventional radiology, cardiology, interventional oncology, pulmonology, and urology. The company was founded by Theodore P. Abraham in 2012 and is headquartered in Baltimore, MD. | Electronic Technology |
Rasio Therapeutics, Inc. |
- Beurs
- Insiders
- Todd Chappell
- Ervaring